Medtronic CEO Ishrak praised for steering company in rough waters


Two years into the tenure of Medtronic CEO Omar Ishrak, MPR visits the Minnesota-based company and reports that the executive is winning praise for improving the bottom line, even as the global medical device giant has struggled through a variety of difficulties.

Medtronic's stock is up about 45 percent and sales have increased since Ishrak took the helm, MPR reported.

Profits went up 16 percent during Ishrak's first year and fell about 4 percent in the second year, but profits remain above where they were a few years ago, MPR reports.

Ishrak has won accolades for the way he has handled controversies, including criticism of the company's much-criticized Infuse spine fusion product, and for being a steady hand steering the company through uncertainty related to the economy, heath care reform, and sagging demand for key products, MPR reports.

Investors Business Daily earlier this month reported more positive numbers: "It's hard to beat Medtronic for steady share price action, earnings and dividend growth lately. Shares of the world's biggest maker of medical devices have risen 27 percent this year, easily beating the S&P 500. They're up 38 percent from a year ago and 73 percent from a bottom of 30.18 in August 2011."

Among the company's recent projects is an artificial pancreas, Reuters reported.

Included in Ishrak's priorities: expanding into emerging markets like China and India, which has been even more challenging than he expected, the Business Journal reported last month.

Ishrak has a $1.2 million salary, with $6.2 million in total compensation for the year that ended April 30, the Star Tribune reported.

Next Up

Leah Ottman, aka LOTT

Acclaimed Minneapolis violinist and singer Leah Ottman dies at 33

She also performed as LOTT, the name of her solo project.

Target gift card

Holiday shopping? Target gift cards are discounted this weekend

You have to be a Target Circle member, but that's free to join.

vote, vote now

MN Supreme Court dismisses attempt to block election certification

Another legal defeat for Republicans challenging the election.

prison, Rush City cell block

Another Minnesota prison inmate dies after COVID-19 diagnosis

The virus has killed at least six Minnesota inmates.

leech lake band of ojibwe sign

11,760 acres of land wrongly taken from Leech Lake Band of Ojibwe will be returned

The Senate and now the House have passed a bill that effectively returns the land. It's now headed for the president's signature.

Karl-Anthony Towns

Timberwolves release first half of 2020-21 regular season schedule

The second half of the schedule will be announced at a later date.

reindeer como zoo

Watch live: Como Zoo's live reindeer cam is back for December

The live feed will run 24/7 allowing you to keep an eye on Santa's antlered helpers.


Three simple ways to boost your immune health heading into winter

Eating right is one thing, but there are other ways to stay healthy as the days shorten.


CEO: Medtronic's focus paying off

After a solid last year and last quarter, Medtronic Inc. CEO Omar Ishrak is reiterating that his company's commitment is to growth through globalization, innovation and enhancing value, not just creating new medical technology products. It's what Ishrak has consistently preached in the year-plus since he took the helm at the world's largest medical device company.

Is Medtronic going after India's largest med-tech company?

A respected Indian business publication is reporting that Medtronic is negotiating with an Indian medical technology company to make a strategic investment in it. Trivitron Healthcare is reportedly India’s largest med tech company. The Fridley-based company has not commented specifically on the deal, however, CEO Omar Ishrak has made no secrets about his interest in India.

Medtronic cutting 1,000 jobs despite growing profits

The Fridley-based medical device maker plans to eliminate positions in facilities around the globe, including 220 positions at its Mounds View-based division. Medtronic topped expectations in the fourth quarter, but continues to struggle with the sale of heart rhythm devices as well as devices used in spine surgery.